• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
SOLY

SOLY

Soliton, Inc.

NASDAQHealthcareMedical - DevicesUS

USD22.58

+0.00 (+0.00%)

Company Profile

CEO

Christopher C. Capelli

IPO Date

2019-02-19

Sector

Healthcare

Industry

Medical - Devices

Exchange

NASDAQ

Country

US

Market Metrics

Open

$22.56

Prev. Close

$22.58

Day Low

$22.56

Day High

$22.59

52W Low

$7.53

52W High

$22.60

Volume

1.35M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

45.1%

Avg Negative

10.1%

Avg Neutral

44.6%

News Feed

Soliton (SOLY) is in Overbought Territory: What's Next?

Zacks Investment Research·5/13/2021·↓ negative

Soliton Reports First Quarter 2021 Results

PRNewsWire·5/12/2021·↑ positive

Shareholder Alert: Ademi LLP investigates whether Soliton, Inc. has obtained a Fair Price in its transaction with AbbVie

PRNewsWire·5/10/2021·↓ negative

Soliton Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Soliton, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – SOLY

Business Wire·5/10/2021·↓ negative

SOLY Stock: Over 20% Increase Intraday Explanation

Pulse2·5/10/2021·↑ positive

Introducing RESONIC™

PRNewsWire·5/5/2021·↑ positive

Soliton to Report First Quarter 2021 Financial Results on May 13, 2021

PRNewsWire·5/4/2021·↑ positive

Soliton Receives FDA Clearance of Special 510(k)

PRNewsWire·4/29/2021·↑ positive

Soliton Announces Oral Presentation at American Society for Laser Medicine and Surgery Virtual Annual Conference

PRNewsWire·4/27/2021·↑ positive

Soliton Provides Special 510(k) and Commercialization Update

PRNewsWire·4/15/2021·↑ positive